CLINICAL RESEARCH: ARTERIAL REFLECTIONS AND STIFFNESS
Impact of Heart Rate on Central Aortic Pressures and HemodynamicsAnalysis From the CAFE (Conduit Artery Function Evaluation) Study: CAFE-Heart Rate
Bryan Williams, MD*,
Peter S. Lacy, PhD for the CAFE and the ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) Investigators
Department of Cardiovascular Sciences, University of Leicester School of Medicine, and the Leicester NIHR Cardiovascular Biomedical Research Unit, Leicester, United Kingdom
Manuscript received November 19, 2008;
revised manuscript received February 11, 2009,
accepted February 23, 2009.
* Reprint requests and correspondence: Dr. Bryan Williams, Department of Cardiovascular Sciences, University of Leicester, Clinical Sciences Building, Leicester Royal Infirmary, P.O. Box 65, Leicester, LE2 7LX, United Kingdom (Email: bw17{at}le.ac.uk).
Objectives: The CAFE (Conduit Artery Function Evaluation) study showed less effective central aortic pressure lowering with atenolol-based therapy versus amlodipine-based therapy in people with hypertension. The present study examined the importance of heart rate (HR) as a determinant of this effect.
Background: Recent analyses have suggested that beta-blockers are less effective at reducing cardiovascular events than alternative blood pressure (BP)-lowering therapies. There has been much debate about the mechanism for this shortfall in benefit and specifically the role of HR lowering by beta-blockers.
Methods: Central pressures were derived from brachial pressure and radial pulse wave analysis in 2,073 patients, and 7,146 measurements were recorded and analyzed over follow-up for up to 4 years.
Results: There was no impact of HR on brachial systolic or pulse pressures; however, there was a highly significant inverse relationship between HR and central aortic systolic and pulse pressures (p < 0.001). This was dependent on a strong inverse relationship between HR and augmentation index, indicative of increased wave reflection at lower HRs. Multiple regression, adjusted for brachial BP, showed HR to be the major determinant of central pressures. Moreover, HR and brachial BP accounted for 92% of the variability in central systolic and pulse pressures. Consequently, drug-related differences in central aortic pressures were markedly attenuated after adjustment for HR.
Conclusions: When comparing beta-blocker–based treatments with other BP-lowering strategies, HR reduction with beta-blockers is a major mechanism accounting for less effective central aortic pressure reduction per unit change in brachial pressure.
Key Words: beta-blocker heart rate central aortic pressure hypertension
|
Abbreviations and Acronyms
| | AIx = augmentation index | | BP = blood pressure | | HR = heart rate | | PP = pulse pressure |
|
Related Articles
-
The Pulse of Cardiology: Quo Vadis?
- Michael F. O'Rourke and Christopher S. Hayward
J. Am. Coll. Cardiol. 2009 54: 714-717.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A24.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. J. London
Do Let the Blood Pressure Fall: But Maybe Not So Much or So Often
Anesth. Analg.,
July 1, 2011;
113(1):
7 - 9.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M. Barodka, B. L. Joshi, D. E. Berkowitz, C. W. Hogue Jr., and D. Nyhan
Review Article: Implications of Vascular Aging
Anesth. Analg.,
May 1, 2011;
112(5):
1048 - 1060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Cavalcante, J. A. C. Lima, A. Redheuil, and M. H. Al-Mallah
Aortic Stiffness: Current Understanding and Future Directions
J. Am. Coll. Cardiol.,
April 5, 2011;
57(14):
1511 - 1522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Williams, P. S. Lacy, P. Yan, C.-N. Hwee, C. Liang, and C.-M. Ting
Development and Validation of a Novel Method to Derive Central Aortic Systolic Pressure From the Radial Pressure Waveform Using an N-Point Moving Average Method
J. Am. Coll. Cardiol.,
February 22, 2011;
57(8):
951 - 961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Custodis, S. H. Schirmer, M. Baumhakel, G. Heusch, M. Bohm, and U. Laufs
Vascular Pathophysiology in Response to Increased Heart Rate
J. Am. Coll. Cardiol.,
December 7, 2010;
56(24):
1973 - 1983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. van den Bogaard, R. Draijer, B. E. Westerhof, A. H. van den Meiracker, G. A. van Montfrans, and B.-J. H. van den Born
Effects on Peripheral and Central Blood Pressure of Cocoa With Natural or High-Dose Theobromine: A Randomized, Double-Blind Crossover Trial
Hypertension,
November 1, 2010;
56(5):
839 - 846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Manisty, J. Mayet, R. J. Tapp, K. H. Parker, P. Sever, N. H. Poulter, S. A. M. Thom, A. D. Hughes, and on behalf of the ASCOT Investigators
Wave Reflection Predicts Cardiovascular Events in Hypertensive Individuals Independent of Blood Pressure and Other Cardiovascular Risk Factors: An ASCOT (Anglo-Scandinavian Cardiac Outcome Trial) Substudy
J. Am. Coll. Cardiol.,
June 29, 2010;
56(1):
24 - 30.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Boutouyrie, A. Achouba, P. Trunet, S. Laurent, and for the EXPLOR Trialist Group
Amlodipine-Valsartan Combination Decreases Central Systolic Blood Pressure More Effectively Than the Amlodipine-Atenolol Combination: The EXPLOR Study
Hypertension,
June 1, 2010;
55(6):
1314 - 1322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, et al.
Highlights of the Year in JACC 2009
J. Am. Coll. Cardiol.,
January 26, 2010;
55(4):
380 - 407.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. O'Rourke and C. S. Hayward
The Pulse of Cardiology: Quo Vadis?
J. Am. Coll. Cardiol.,
August 18, 2009;
54(8):
714 - 717.
[Full Text]
[PDF]
|
 |
|
|